The rising threat of antimicrobial resistance (AMR) continues to expose deep structural weaknesses in global pharmaceutical markets, with drug-resistant infections projected to claim nearly two million lives annually by 2050 unless investment and policy responses accelerate, according to the 2026 AMR Benchmark published by the Access to Medicine Foundation. The benchmark, released on March 10,…
Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical company, becoming the first Lebanese company to localize its portfolio in the Kingdom. The agreement covers the manufacturing and supply of several EU & Japanese licensed Algorithm products. The collaboration will kick off…
As AI accelerates both innovation and risk, Gen Digital’s Q2 2025 Threat Report delivers a clear message: cybercriminals are using technology smarter – and more personally – than ever before. Their findings span AI-powered ransomware, pharmaceutical fraud, social media scams, and a surge in remote access attacks. Let’s unpack the most urgent threats facing consumers…
